European Society of Cardiology
Fasting not necessary for cardiac catheterization procedures with conscious sedation
Not fasting before cardiac catheterization procedures with conscious sedation was noninferior and likely superior to fasting for safety, and improved patient satisfaction, researchers reported at the European Society of Cardiology Congress.
TAVR superior to surgery at 1 year for women with severe aortic stenosis: RHEIA
Women with symptomatic severe aortic stenosis had better outcomes at 1 year after transcatheter aortic valve replacement with a balloon-expandable valve compared with women who underwent surgery, according to new data from the RHEIA trial.
Coronary implant noninferior to DES at 1 year, tied to event reduction after 6 months
The bioadaptor implant adaptable to vessel physiology was noninferior to a drug-eluting stent for target lesion failure at 1 year, and reduced event rates vs. the DES after 6 months, researchers reported.
Benefits of weight loss from bariatric surgery extend to blood pressure control
Bariatric surgery for weight loss was associated with improvements in blood pressure and antihypertensive use among patients with obesity compared with medical therapy and/or lifestyle management, a speaker reported.
Pulmonary vein isolation benefits patients with atrial fibrillation vs. sham procedure
Pulmonary vein isolation was associated with genuine improvements in patients with atrial fibrillation at 6 months that cannot be attributed to a placebo effect, researchers reported at the European Society of Cardiology Congress.
Point-of-care testing may expedite movement of patients with ACS from ED to cardiac ward
A bedside cardiac troponin test could reduce the time patients with ACS spend in the ED by nearly 45 minutes, with the availability of a doctor to assess the situation and move them to the cardiac ward, a speaker reported.
Edoxaban reduced clinical events with less bleeding vs. dual therapy for AF, stable CAD
Edoxaban monotherapy for patients with atrial fibrillation and stable coronary disease reduced risk for adverse clinical events, mainly driven by lower bleeding risk, compared with dual antiplatelet therapy, a speaker reported.
AI decision support tool did not improve outcomes among patients with suspected MI
An AI decision support tool embedded in routine care did not meaningfully improve outcomes for patients presenting to the ED with myocardial injury, but showed signs of benefit in an all-comer cohort, a speaker reported.
Semaglutide cuts risk for worsening heart failure, CV death among adults with HFpEF
Semaglutide cut the risk for worsening heart failure and CV death for adults with HF with preserved ejection fraction, according to data presented at the European Society of Cardiology Congress and simultaneously published in The Lancet.
Temporary interruption of anticoagulant use during TAVR appears safe
Halting oral anticoagulation during transcatheter aortic valve replacement was not noninferior to anticoagulant continuation, but conferred lower bleeding risk and had no impact on thromboembolic risk, a speaker reported.